Outcomes of high‑dose methotrexate for CNS prophylaxis in diffuse large B‑cell lymphoma with an intermediate or high CNS‑International Prognostic Index: A single‑center retrospective cohort study

Central nervous system (CNS) relapse in patients with diffuse large B-cell lymphoma (DLBCL) is rare (2-5% of cases), but is a devastating complication with a poor survival rate. The administration of high-dose methotrexate (HDMTX) for CNS prophylaxis in patients with DLBCL is controversial and varia...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Mansour, Mubarak, Absi, Ahmed, Al-Μufti, Roula, Alahmadi, Majed, El-Ηemaidi, Ihab, Alamoudi, Sameer, Eldadah, Saleem, Aga, Syed Sameer, Khan, Muhammed A., Alsaeed, Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627119/
https://www.ncbi.nlm.nih.gov/pubmed/36338604
http://dx.doi.org/10.3892/mco.2022.2592

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627119/
https://www.ncbi.nlm.nih.gov/pubmed/36338604
http://dx.doi.org/10.3892/mco.2022.2592

Ejemplares similares